| |
| |
|
| Insider
Information: |
Shannon John Patrick Jr |
| Relationship: |
See Remarks |
| City: |
Morristown |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 63.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Durata Therapeutics, Inc. |
DRTX |
Chief Commercial Officer |
2014-11-17 |
0 |
2012-07-24 |
0 |
Premium* |
|
|
Xeris Pharmaceuticals Inc |
XERS |
See Remarks |
2021-10-05 |
0 |
2018-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2021-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(263,829) |
0 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
271,224 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-06-30 |
4 |
A |
$2.26 |
$8,432 |
D/D |
3,731 |
121,224 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-05-13 |
4 |
B |
$3.55 |
$77,994 |
D/D |
22,000 |
117,493 |
2.74 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-05-08 |
4 |
B |
$3.20 |
$25,219 |
D/D |
7,886 |
95,493 |
2.74 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-02-14 |
4 |
B |
$4.15 |
$49,999 |
D/D |
12,048 |
22,607 |
2.74 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
87,607 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2019-12-31 |
4 |
A |
$5.99 |
$2,624 |
D/D |
438 |
10,559 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2019-07-01 |
4 |
A |
$9.72 |
$11,061 |
D/D |
1,138 |
10,121 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
8,983 |
8,983 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Chief Commercial Officer |
• – – |
2014-11-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,000) |
0 |
0 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Chief Commercial Officer |
• – – |
2014-08-12 |
4 |
B |
$13.72 |
$41,160 |
D/D |
3,000 |
11,000 |
2.74 |
- |
|
| DRTX |
Durata Therapeutics, Inc. |
Chief Commercial Officer |
• – – |
2012-07-24 |
5 |
B |
$9.00 |
$72,000 |
D/D |
8,000 |
8,000 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
